137 related articles for article (PubMed ID: 15320807)
1. Designing of Novel Carbonic Anhydrase Inhibitors and Activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):51-70. PubMed ID: 15320807
[TBL] [Abstract][Full Text] [Related]
2. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors.
Supuran CT; Scozzafava A; Casini A
Med Res Rev; 2003 Mar; 23(2):146-89. PubMed ID: 12500287
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
Pastorekova S; Parkkila S; Pastorek J; Supuran CT
J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrases as targets for medicinal chemistry.
Supuran CT; Scozzafava A
Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.
Temperini C; Scozzafava A; Vullo D; Supuran CT
J Med Chem; 2006 May; 49(10):3019-27. PubMed ID: 16686544
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.
Temperini C; Scozzafava A; Vullo D; Supuran CT
Chemistry; 2006 Sep; 12(27):7057-66. PubMed ID: 16807956
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrases as drug targets--an overview.
Supuran CT
Curr Top Med Chem; 2007; 7(9):825-33. PubMed ID: 17504127
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
Temperini C; Scozzafava A; Puccetti L; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors.
Supuran CT
Bioorg Med Chem Lett; 2010 Jun; 20(12):3467-74. PubMed ID: 20529676
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2009 Feb; 17(3):1214-21. PubMed ID: 19119014
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.
Durdagi S; Şentürk M; Ekinci D; Balaydın HT; Göksu S; Küfrevioğlu Öİ; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2011 Feb; 19(4):1381-9. PubMed ID: 21282059
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.
Supuran CT
Nat Rev Drug Discov; 2008 Feb; 7(2):168-81. PubMed ID: 18167490
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).
Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Mar; 18(5):1583-7. PubMed ID: 18242985
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV.
Temperini C; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2008 Sep; 16(18):8373-8. PubMed ID: 18774300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
